This paper summarizes experimental data and theoretical conare the level of sensitivity that is deemed relevant for the study The following discussion of detection methods will be in the 
All cell lines and treatment of AML samples and other methods have been extensively described in our earlier papers. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Additional specific details are given when considered Introduction useful, in the Results section.
It is the purpose of this paper to describe our experience with assays for the P-glycoprotein (Pgp)-mediated multidrug resistFluorescence laser scan microscopy ance (MDR) phenotype in adult acute myeloid leukemia (AML). The emphasis is on the measurement of Pgp function, Cells were incubated with daunorubicin (concentration range in comparison with measurements of Pgp protein expression.
0.05-4 M) for 75 min at 37°C in medium with 10% fetal Measurement of 'Pgp function' or 'activity' implies the assesscalf serum (FCS) and 20 mM Hepes (pH = 7.4) as described ment of a drug (or dye) transport-related parameter, such as previously. [1] [2] [3] About 0.3 × 10 6 KB cells or 0.6 × 10 6 leukemic uptake, efflux, steady-state accumulation or intracellular discells per ml were incubated with regular shaking. After incutribution. Our experience is built upon extensive comparison bation the cells were washed twice with ice-cold phosphateof methods to determine Pgp MDR in tumor cell lines, also buffered saline (PBS) and cytocentrifuged for 5 min at 350 with low levels of Pgp/MDR1 expression, [1] [2] [3] [4] [5] [6] experiments and r.p.m. on slides precoated with 0.1% bovine serum albumin model calculations intended to understand the kinetics of Pgpsolution. Per cytospin 100 l containing 35 000 KB cells or mediated daunorubicin transport 7, 8 and the application of this 80 000 leukemic cells were used. After spinning, the cells knowledge to measure Pgp in human AML.
9-11 We emphasize were immediately fixed for 5 min with 3.6% formaldehyde the reasons for choosing certain methods above others and solution at room temperature and washed with water. Excess when appropriate refer to related methods used by other water was removed with tissue and the spins were dried horilaboratories.
zontally in the dark. Criteria that need to be determined before starting a study Recording of the fluorescence was done initially on a Zeiss into the clinical relevance of Pgp for chemotherapy resistance laser scanning microscope 41 (Carl-Zeiss, Oberkochen, Germany) using the Argon laser providing a 488 nm beam. Emission was measured at wavelengths longer than 515 nm.
to-pixel distance of 0.3 m at the cellular level. Analysis of expression. 9 It appeared that the binding of MRK16 to these cells was not saturable up to 100 g/ml at 0°C or the images was done with a Kontron Image Processing System (IPS, Kontron Bindanalyse, Eching, Germany). During this room temperature. However, for KB8 and KB8-5 cells a ratio of the mean fluorescence of MRK16 divided by study the analysis was continued on a new inverted confocal laser scanning microscope TCS 4D (Leica, Heidelberg, isotype-matched control (with FITC-labelled second antibody) was obtained upon the use of 25 g/ml MRK16 Germany) equipped with an Ar/Kr laser. A 40×/1.00-0.50 or 63×/1.40 oil lens was used. Scanning, image processing and (60 min labelling, room temperature) which allowed sufficient resolution to measure Pgp expression over the microscope control were done using an OS9 minicomputer. Quantification of the images was done with Leica Q500MC whole range as occurring in AML (see Table 1 and Ref.
10). QWin version v01.00. Fluorescence of daunorubicin was measured in at least 100-200 cells on three to four images (2) This ratio was higher when a FACSCalibur was used rather than a FACScan with the same labeling procedure (see from two cytospins. The background (from an area between the cells) was subtracted and the fluorescence divided by the Pgp function time (eg overnight) the drug transport function may become less (see also below under 'radiolabelled drug We have chosen to put much effort into the reliable measurement of Pgp function in AML for a number of practical and assays'). One paper explicity reports results of experiments designed to study the effect of storage conditions of AMLs theoretical reasons. First, as discussed previously, the measurement of Pgp protein with antibody-based techniques on drug transport function.
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(3) To ensure uniform conditions after Ficoll separation, we poses inherent problems with the discrimination of background staining from a low specific signal. This called for an keep the cells at 4°C in medium with 10% fetal calf serum and 20 mM Hepes (pH 7.4 when at 37°C). Protein in the entirely independent technique to confirm Pgp measurements. Second, although probably not of major concern, potential medium is probably important for good condition of the cells and it will help to prevent (lipophilic) drugs from differences in Pgp activity by post-translational modification of Pgp might exist. Third, the measurement of Pgp drug transsticking to plastic or glass tubes. (4) When not assayed the same day cells are frozen in liquid port function allows estimation of the magnitude of the effect that Pgp expression may have on the drug accumulation and nitrogen and after thawing they are allowed to rehydrate and recover for 1-2 h in the same protein-containing by inference on its cytostatic effect. medium at 37°C. 10, 17, 18 In summary, it is advisable to assay AMLs for Pgp activity as rapidly as possible and with as little manipulation as possible, in order to minimize the Pgp function: assay conditions chance that alterations in plasma membranes lead to an (apparently) altered test result. It is important to keep in mind when performing an assay for the activity of a drug transporter that one works with viable (5) A further important general point is the use of a concentration of probe (radioactive or fluorescent) low enough cells. In order not to compromise or alter the function of the transporter protein not only the epitope of the protein as not to saturate the drug pump; otherwise, relatively small effects on drug accumulation or efflux will be measured recognized by an antibody has to be conserved. In addition, the complete integrity of the protein, its direct environment despite the presence of pump activity. Saturation kinetics have not been studied for most probes. Therefore it seems (plasma membrane) as well as the concentrations of co-subsafe to use a concentration not higher than needed for the sensitivity of the assay. For daunorubicin we use 0.5 M AMLs. 9,10 The following points require special attention.
(1) Although these types of assays may not be generally appli- The choice of a certain combination of probe, modulator and assay conditions (concentration, time, blast population and corrected the absolute drug accumulation values for cell volume, normalizing to the mean volprotein composition, pH etc) will necessarily have to be based on both theoretical and pragmatic reasons. An important lead ume of all samples in the study. Such a normalization was shown to increase the predictive value of flow cytometric for the use of daunorubicin is that it is an agent used for the treatment of a certain population of AML patients. However, daunorubicin assessment in cell lines. 22 We have observed significant differences in mean steady-state it became clear that a more sensitive probe was needed to obtain a more reliable and practical assay. Such an assay accumulation of vincristine and non-steady-state accumulation of doxorubicin in blast samples from clinically appeared to be a 60-90 min (non-steady-state) accumulation of R123 (200 ng/ml = 0.5 M) with and without 2 M PSC833. responding or refractory AML patients. 9 In that study a difference between mean steady-state daunorubicin accumuAn often-applied R123 efflux assay 25 was not chosen by us, because: (1) we wished to keep the assay as simple as possible lation between both patients groups was observed, but did not reach significance. Nevertheless, two other papers (short duration, minimal washing of cells); (2) the accumulation assay appeared sensitive enough to detect Pgp activity report a significant difference of intracellular daunorubicin accumulation in AML (by flow cytometry) between in AMLs; 10 and (3) (1) For theoretical reasons, any assay measuring the difference of cellular probe accumulation with or without a moducells, since we had added 0.025% DNAse I during these assays in order to lower the background. The addition of lator is preferred to an absolute probe accumulation assay. The latter is much more likely to be influenced by factors DNAse I is an important improvement in anthracycline accumulation assays especially for samples with low drug such as DNA content (anthracyclines, other DNA binders), pH (BCECF-AM), number of mitochondria (R123) plasma uptake. Examples are shown in Table 3 for doxorubicin, where the accumulation increases upon overnight storage membrane potential (R123, DiOC 2 (3)), Ca 2+ ions (Fluo3-AM) or other variables than is the effect of a well-chosen under different conditions. Although the magnitude of the difference may be higher for non-steady-state (75 min) modulator on basal probe uptake. In addition, the choice of modulator may allow further discrimination of Pgp and doxorubicin accumulation than for other drugs, these data clearly show that one cannot assume a priori that cellular MRP-mediated dye efflux. Organic anions, in particular, are inhibitors of MRP, but not of Pgp-mediated drug drug uptake/efflux characteristics are unaltered as long as cells remain (trypan-blue) viable. Similarly, it cannot be efflux.
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(2) The concentration of the modulator of choice has to be assumed that modulation of drug uptake will be unaltered 10 For the combination A double labelling procedure with R123 and FITC labels is impossible and the combination with PE label still requires R123/PSC833, it is short-term accumulation that provides Pgp specificity. 1, 27 Since some MRP-overexpressing cell extensive compensation. 25 For that reason, the procedure of Leith et al 17 who used DiOC 2 (3) combined with PE-labelled lines respond to PSC833, its Pgp specificity is not absolute. Verapamil may even be less specific in that respect. 28 The CD33 or CD34 or MRK16 detection with Texas Red, seems the preferred method for double labelling procedures. Howabsence of a good correlation between the effects of cyclosporin A (1 or 3 g/ml) on daunorubicin uptake 23, 29 ever, the need to work at 4°C in order to prevent efflux of DiOC 2 (3) does not allow optimal labelling with MRK16 (see or DiOC 2 (3) efflux 17 in AML with MRK16 labelling, may be an indication for a Pgp-independent effect of cyclospobefore). Therefore, there is still a need to develop more convenient and sensitive double-labelling procedures. rin A. One other study also reported a good correlation between an R123/cyclosporin A and a daunorubicin/cyclosporin A assay, but again not with MRK16. 30 A suboptimal Pgp analysis, such as representation of the Pgp protein and function: fluorescence microscopy data as percentage positive cells with a cut-off level of 5% 30 or labelling at 4°C, 10 might partially contribute to these observations. In many studies on MDR it has been noted by the authors that there is not only a decreased net drug accumulation in MDR (4) When applying fluorescence measurements it is necessary always to be aware of interaction of the modulator with cells, but also a quantitative change in the distribution of the drug over various subcellular localizations. This phenomenon, the fluorescence of the probe in its cellular environment. The magnitude and frequency of such potential interacthat has been studied mainly for anthracyclines because of their favorable fluorescence properties, has not been mechantions can first be checked with sensitive tumor cell lines, where there should be no effect. For example, we have istically explained until now. One of the more favored hypotheses is that cytoplasmic vesicular or vacuolar structures in seen quenching of the R123 fluorescence in some cell lines by PSC 833, not related to a drug pump. However, MDR cells accumulate more drug than in sensitive cells (or that there are more such structures), which has been suggested the highly favorable properties of R123 as a Pgp substrate outweigh these effects.
to contribute to the resistance by exporting drug from the cell by exocytotic-like mechanisms. 36 However, irrespective of the (5) Another property to be aware of in the design of a Pgp activity assay is whether the modulator itself is being functional role of cytoplasmic drug stores in the MDR phenotype, the phenomenon can be measured as an apparent effluxed (such as verapamil) or is retained in the cells for a prolonged time, irrespective of Pgp expression (PSC decrease in anthracycline nuclear/cytoplasmic (N/C) ratio in MDR cells. We have quantified the N/C ratio by fluorescence 833). 1, 31 In the latter case, the cells cannot be loaded with dye in the presence of the modulator if subsequently the laser scan microscopy in MDR cell lines and shown that it correlates with resistance even in very low resistant tumor cell dye efflux is to be studied. 1 (6) Finally, one has to be aware that the protein concentration lines. 4, 5 Recently we have shown its applicability in AMLs. The method works best for doxorubicin rather than daunoruband composition of the medium is a determinant of the magnitude of the effect of many highly protein-binding icin as daunorubicin has a relatively high accumulation in cytoplasmic structures, which makes the detection of MDR by modulators. 32, 33 Thus, a certain value holds only for the particular medium composition. In principle, a double-labelling with daunorubicin and antimodified the N/C ratio measurements described above to allow a more general application. The criteria that we used body, eg MRK16 (with FITC-labelled second antibody) is possible. We have used such a procedure to detect the effect of for the development of a method for the measurement of Pgp function by fluorescence laser scan microscopy with digital PSC 833 on daunorubicin accumulation in Pgp-overexpressing (KB8-5) cells in a mixture with sensitive and MRP-overeximage processing were: lost. 37 In this way the pool of daunorubicin in the nucleus will
be measured, which is the important pool for the cytotoxic orescent label and filters and/or compensation, Pgp in the modulation data were also available; the latter was used to subdivplasma membrane can be quantified in the same single cells ide the AMLs into three groups of samples with a R123 modulation (criterium 2). We chose to measure the effect of PSC 833 on Ͻ1.5 (n = 12), 1.5-2.0 (n = 2) and Ͼ2.0 (n = 3) respectively.
the nuclear daunorubicin fluorescence/area. The linearity of
the method (criterium 3) was investigated in KB3-1 and KB8-5 cells (see Figure 1 ). The application of 1-2 M daunorubicin with an intermediate or high R123 modulation (see Table 4 ). appeared to be a good choice (see Figure 1) , because the Thus, although the method works and we have found higher values were within a linear range and because the nuclear modulation of the nuclear daunorubicin fluorescence of indifluorescence was high enough to avoid problems with backvidual AMLs with high Pgp expression, the resolution of the ground from autofluorescence in the nuclei. In KB8-5 cells the method cannot be considered high enough for a statistical daunorubicin fluorescence without PSC 833 was just above reliable detection of the Pgp function in most AML samples background; however, such a large effect of Pgp expression in a single experiment by measuring 100-200 cells. Therefore, is rarely or never seen in AMLs. Moreover, the modulation to meet the criterium of sensitivity we have sought to improve effect of PSC 833 was 4.5 ± 1.2 in KB8-5 cells (see Table 4) this method by using better Pgp substrates with fluorescence in good agreement with a factor 3.1 ± 1.2 for modulation of enhancement upon DNA binding, which can be detected by whole cell daunorubicin accumulation. 1 The method an argon laser. Such probes are some of the SYTO R live-cell appeared practical because the handling of the cells was simnucleic acid stains, 38 which can be used in the same way as ple and reproducible and because the fixed cytospins could described for daunorubicin 47 (Molecular Probes, Eugene, be stored at room temperature in the dark for at least a week OR, USA). without loss of fluorescence (criterium 4). Then, as far as the sensitivity is concerned (criterium 5) it can be seen from Table  4 , that for KB8 cells a modulation value of 1.36 ± 0.38 was Discussion found. Such values were also found for some AML samples
In this paper we have attempted to account for our methodological choices for the measurement of Pgp-mediated MDR in AML. Since it is impossible to compare directly all possible permutations of experimental conditions, antibodies, probes and modulators our choices are not necessarily the ony possible or the best way of measuring Pgp MDR. However, regarding our data, together with some other recent methodological papers, [15] [16] [17] 21 it seems justifiable to draw some general conclusions.
• To determine the threshold of sensitivity and reproducibility of any method a laboratory should use at least one cell line that is Pgp-negative and one with a very low level of Pgp expression (10 000-50 000 Pgp molecules per cell, see Table 2 ).
• Functional Pgp assays seem to be more sensitive than presently described immunocytochemical methods. Foremost, however, is to realize that working with live cells accordingly strict protocols for handling the cells must be can be used if necessary. typical identification of the highest Pgp-expressing subpop-
Contribution to response Unknown
ulations in AML and their relevance for tumor behaviour and prognosis will be a topic for future studies.
Data are from the same group of (mainly de novo) AML samples.
We have compared the flow cytometric Pgp activity assays (R123 and daunorubicin) with radiolabelled accumulation us and showed that the contribution of the N/C distribution assays for daunorubicin and vincristine. Since we have found difference to resistance is always small compared to the a high correlation between the effect of PSC 833 on radioaccumulation deficit 6 (unpublished). labelled or fluorescent daunorubicin we feel confident that Second, in a 4-day MTT-based cytotoxicity assay of AML the latter represents an absolute value for the increase. Upon blasts we saw a variation in the IC 50 for daunorubicin of about blocking Pgp with 2 M PSC 833 this increase falls within the 15 between individual samples, which is much larger than the range of a 0-50% increase, in good agreement with two other factor 3 observed in the accumulation test (see Table 5 ). This studies. 39, 40 From the radiolabelled daunorubicin measuresuggests that the IC 50 for daunorubicin as measured in an MTT ments we calculated that the absolute value of (volumetest does not reflect differences in intracellular exposure. corrected) daunorubicin accumulation was 58 ± 15 pmol/10 6 However, since it is not known whether an MTT assay for cells (mean ± s.d., n = 62 leukemias; range 33-91; one daunorubicin has predictive value for treatment outcome in extreme value of 123 excluded) (incubation 0.5 M daunorub-AML, it cannot be used at present as a reference value for icin, medium + 10% FCS, 20 mM Hepes, pH 7.4, 75 min other tests. 37°C). These data allow us to speculate further about the Third, it is possible to calculate a theoretical curve of the quantitative role Pgp may play in the response of patients with effect of Pgp expression on the intracellular free drug concen-AML to chemotherapy. The question that has to be addressed tration. Such a curve is shown in Figure 2 . It shows that with is, whether there is any evidence from drug uptake studies increasing Pgp expression (of course) the ratio of intracellular that a (Pgp-mediated?) decrease of daunorubicin accumulation contributes to the in vivo failure to respond to chemotherapy or to short (disease-free) survival of AML patients.
The flow cytometric monitoring of daunorubicin concentrations in peripheral blasts and bone marrow cells from AML patients 1 h after in vivo administration of a daunorubicincontaining regimen showed a tendency of a higher fluorescence (not reaching significance) in cells from patients with a complete response compared to partial response (but not compared to no response). 41 However, because the fluorescence does not reach values as high as after in vitro loading with 2 M daunorubicin, the background fluorescence will play a relatively large role in such ex vivo measurements.
As discussed before, we found a factor three difference in mean in vitro daunorubicin accumulation in AMLs, which may or may not be related to a drug pump. However, in the same population, the effect of blocking the Pgp activity (with 2 M PSC 833) was a maximal 35% increase of daunorubicin accumulation, with no apparent differences between cases 
